Literature DB >> 15721450

Re: "clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation".

Joseph Menczer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15721450     DOI： 10.1016/j.ygyno.2004.10.043

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  2 in total

Review 1.  Ovarian cancer: the duplicity of CA125 measurement.

Authors:  Amer K Karam; Beth Y Karlan
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

2.  CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery.

Authors:  Fang Wang; Yanfen Ye; Xia Xu; Xuehui Zhou; Jinhua Wang; Xiaoxiang Chen
Journal:  J Ovarian Res       Date:  2013-02-13       Impact factor: 4.234
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.